Expand DAWN Menu
DAWN MENU

DAWN Stock Summary and Trading Ideas (Day One Biopharmaceuticals | NASDAQ:DAWN)

Charts for Today's Stock Price and Implied Volatility in Day One Biopharmaceuticals

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for DAWN by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Day One Biopharmaceuticals (DAWN) Frequently Asked Questions

What does Day One Biopharmaceuticals do?

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.

What symbol and exchange does Day One Biopharmaceuticals shares trade?

Day One Biopharmaceuticals trades on the NASDAQ stock market under the symbol DAWN.

What is Day One Biopharmaceuticals stock price doing today?

As of November 15, 2024, DAWN stock price declined to $13.31 with 1,736,599 million shares trading.

What is Day One Biopharmaceuticals's Beta?

DAWN has a beta of 1.17, meaning it tends to be more sensitive to market movements. DAWN has a correlation of 0.08 to the broad based SPY ETF.

How much is Day One Biopharmaceuticals worth?

DAWN has a market cap of $1.34 billion. This is considered a Small Cap stock.

How much money does Day One Biopharmaceuticals make?

Last quarter Day One Biopharmaceuticals reported $94 million in Revenue and $.38 earnings per share. This beat revenue expectation by $70 million and exceeded earnings estimates by $.79.

What is the highest and lowest price Day One Biopharmaceuticals traded in the last 3 year period?

In the last 3 years, DAWN traded as high as $28.35 and as low as $5.44.

What are the top ETFs holding Day One Biopharmaceuticals?

The top ETF exchange traded funds that DAWN belongs to (by Net Assets): VTI, XBI, IWM, VXF, VB.

Is Day One Biopharmaceuticals (DAWN) a good investment?

DAWN has underperformed the market in the last year with a price return of +9.4% while the SPY ETF gained +32.1%. DAWN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -0.7% and -9.6%, respectively, while the SPY returned +8.0% and +3.0%, respectively.

What are the support and resistance levels for Day One Biopharmaceuticals (DAWN)?

DAWN support price is $13.84 and resistance is $14.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DAWN shares will trade within this expected range on the day.